AI-Powered Pathology (Paige AI)

Paige AI's FDA-cleared prostate cancer detection system was deployed in 50+ major cancer centers in 2025, analyzing whole-slide pathology images to identify cancerous cells with 97.8% sensitivity — significantly higher than human pathologists alone. Its Paige Prostate and Paige Breast tools processed 1 million pathology slides in 2024, with studies showing AI assistance reduced both false positive and false negative rates for oncologists.